Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Jul. 30, 2016	Aug. 01, 2015
Cash flows from operating activities:
Net income	$ 565,507	$ 600,573
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	100,424	97,459
Amortization of intangibles	55,703	73,791
Stock-based compensation expense	48,187	52,836
Gains (Losses) on Extinguishment of Debt	(3,290)	0
Excess tax benefit-stock options	(7,180)	(22,150)
Deferred income taxes	5,072	(26,564)
Other non-cash activity	2,371	9,402
Changes in operating assets and liabilities	20,537	(75,524)
Total adjustments	228,404	109,250
Net cash provided by operating activities	793,911	709,823
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	(5,855,930)	(4,275,797)
Maturities of short-term available-for-sale investments	5,010,942	2,939,035
Sales of short-term available-for-sale investments	290,071	1,091,648
Additions to property, plant and equipment	(86,173)	(108,153)
Payments for acquisitions, net of cash acquired	(2,203)	(7,065)
Increase in other assets	(18,048)	(9,377)
Net cash used for investing activities	(661,341)	(369,709)
Cash flows from financing activities:
Proceeds from (Repayments of) Debt	(378,156)	0
Payments for Derivative Instrument, Financing Activities	(33,430)	0
Proceeds from debt	1,235,331	0
Payments of Financing Costs	(22,208)	0
Dividend payments to shareholders	(383,537)	(365,477)
Repurchase of common stock	(368,649)	(115,251)
Proceeds from employee stock plans	39,342	114,871
Contingent consideration payment	0	1,767
Changes in other financing activities	(7,423)	(3,224)
Excess tax benefit-stock options	7,180	22,150
Net cash provided by (used for) financing activities	88,450	(348,698)
Effect of exchange rate changes on cash	(1,703)	(3,152)
Net increase (decrease) in cash and cash equivalents	219,317	(11,736)
Cash and cash equivalents at beginning of period	884,353	569,233
Cash and cash equivalents at end of period	$ 1,103,670	$ 557,497